May 6, 2020 / 6:22 PM / a month ago

BRIEF-U.S. FDA Approves Novartis' Tabrecta To Treat Adults With Metastatic Non-Small Cell Lung Cancer

May 6 (Reuters) - U.S. FDA:

* U.S. FDA - APPROVES NOVARTIS' TABRECTA TO TREAT ADULTS WITH METASTATIC NON-SMALL CELL LUNG CANCER

* FDA SAYS TABRECTA APPROVED FOR LUNG CANCER PATIENTS WHOSE TUMORS HAVE MUTATION LEADING TO MET EXON 14 SKIPPING AS DETECTED BY FDA-APPROVED TEST

* FDA SAYS TABRECTA TABLETS APPROVED UNDER ACCELERATED APPROVAL Source text: (bit.ly/3cfgfmM) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below